Chemoinformaics analysis of Pentobarbital Sodium
| Molecular Weight | 248.258 | nRot | 4 |
| Heavy Atom Molecular Weight | 231.122 | nRig | 8 |
| Exact Molecular Weight | 248.114 | nRing | 1 |
| Solubility: LogS | -1.727 | nHRing | 1 |
| Solubility: LogP | 1.399 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 58.4215 |
| nHD | 1 | BPOL | 21.3685 |
| QED | 0.693 |
| Synth | 4.356 |
| Natural Product Likeliness | 0.2 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.191 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.656 |
| MDCK | 0.0000268 |
| BBB | 0.999 |
| PPB | 0.482611 |
| VDSS | 0.791 |
| FU | 0.571179 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.765 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.032 |
| CYP2c9-sub | 0.573 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.326 |
| CL | 6.319 |
| T12 | 0.817 |
| hERG | 0.012 |
| Ames | 0.636 |
| ROA | 0.677 |
| SkinSen | 0.104 |
| Carcinogencity | 0.953 |
| EI | 0.009 |
| Respiratory | 0.647 |
| NR-Aromatase | 0.024 |
| Antiviral | Yes |
| Prediction | 0.627975 |